Evidence map›Paper›PMID 25941411›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Reply to Ashktorab et al.: Mutational landscape of colon cancers in African Americans.

Kishore Guda, Martina L Veigl, Vinay Varadan, Arman Nosrati, Lakshmeswari Ravi, James Lutterbaugh, Lydia Beard, James K V Willson, W David Sedwick, Zhenghe John Wang and 6 more

Open access · bronzeAbstract readLetterComment
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Kishore GudaDivision of General Medical Sciences-Oncology, Case Comprehensive Cancer Center, and Department of Medicine.
Martina L VeiglCase Comprehensive Cancer Center, and Department of Medicine.
Vinay VaradanDivision of General Medical Sciences-Oncology, Case Comprehensive Cancer Center, and.
Arman NosratiDivision of Hematology and Oncology.
Lakshmeswari RaviDivision of Hematology and Oncology.
James LutterbaughDivision of Hematology and Oncology.
Lydia BeardDivision of Hematology and Oncology.
James K V WillsonHarold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390; and.
W David SedwickCase Comprehensive Cancer Center, and Department of Medicine, Division of Hematology and Oncology.
Zhenghe John WangCase Comprehensive Cancer Center, and Department of Genetics and Genome Sciences.
Neil MolyneauxDepartment of Genetics and Genome Sciences.
Alexander MironDepartment of Genetics and Genome Sciences.
Mark D AdamsJ. Craig Venter Institute, La Jolla, CA 92037.
Robert C ElstonCase Comprehensive Cancer Center, and Department of Epidemiology and Biostatistics.
Sanford D MarkowitzCase Comprehensive Cancer Center, and Department of Medicine, Division of Hematology and Oncology, Case Medical Center, Case Western Reserve University, Cleveland, OH 44106; sxm10@case.edu.
Joseph E WillisCase Comprehensive Cancer Center, and Department of Medicine, Case Medical Center, Case Western Reserve University, Cleveland, OH 44106; Department of Pathology.
Case Comprehensive Cancer CenterPalmetto Hematology Oncology · USCancer Research And Biostatistics · USCase Western Reserve University · USJ. Craig Venter Institute · USThe University of Texas Southwestern Medical Center · US

Funding

Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
PROTEOMICS CORE FACILITYG12MD007597 · NIMHD · HOWARD UNIVERSITY · PI SOUTHERLAND, WILLIAM M. · 2012 to 2018
$14.8M
NCATS NIH HHS UL1 TR000439NIMHD NIH HHS G12 MD007597
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MutationBlack or African AmericanColonic NeoplasmsFemaleHumansMaleProto-Oncogene ProteinsReceptor, EphA6Tumor Suppressor ProteinsProto-Oncogene ProteinsReceptor, EphA6Tumor Suppressor Proteins

Identifiers

PMID25941411
PMCPMC4460466
OpenAlexW2347167765

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.